NLRP3 Target Analysis Report Summary
About the Target
Based on the provided information, here are some key viewpoints regarding NLRP3:
Glucocorticoid resistance: Patients with idiopathic nephrotic syndrome (INS) may develop resistance to glucocorticoids (GCs) due to epigenetic changes in the NLRP3 gene . This mechanism is related to leukocyte epigenetic changes and may contribute to the development of resistance to GCs in INS patients.
Inflammasome activation: NLRP3 plays a crucial role in both canonical and non-canonical inflammasome activation pathways . Gram-negative bacteria can activate the NLRP3 inflammasome, leading to the release of IL-1beta/IL-18 and pyroptosis. In human monocytes, an alternative NLRP3 inflammasome pathway is activated in response to LPS.
Two-signal model for NLRP3 inflammasome activation: The activation of the NLRP3 inflammasome involves two signals: priming and activation . Priming, which is induced by microbial or endogenous molecules, upregulates NLRP3 expression. Activation occurs through various stimuli like ATP, pore-forming toxins, viral RNA, and particulate matter. K+ efflux, Ca2+ signaling, reactive oxygen species (ROS), mitochondrial dysfunction, and lysosomal rupture are proposed triggers for NLRP3 activation.
Post-translational modifications and regulators of NLRP3: NLRP3 is regulated by post-translational modifications such as phosphorylation, ubiquitination, sumoylation, and S-nitrosylation . These modifications can either positively or negatively affect NLRP3 activation. Additionally, NLRP3 interacts with various proteins and molecules, including ARIH2, BRCC3, FBX12, JNK1, and SENP6/7.
Autophagy and NLRP3: Autophagy plays a role in NLRP3 regulation. Under stress conditions, defective autophagy can lead to the accumulation of damaged mitochondria and activation of the NLRP3 inflammasome, resulting in increased production of IL-1beta and inflammation . On the other hand, p62, an adaptor protein, can stimulate the removal of damaged mitochondria, inhibiting inflammasome activation and pro-inflammatory IL-1beta synthesis.
Overall, NLRP3 is involved in glucocorticoid resistance, inflammasome activation, and various post-translational modifications. Its modulation and regulation are crucial in the context of immune responses and inflammatory processes.
- NLRP3 expression is regulated by various transcription factors, including NF-kappaB, GFI1, AhR, NR1D1, and NFAT5.
- NLRP3 inflammasome priming is mediated by post-translational modifications independent of transcription.
- Classical activation of the NLRP3 inflammasome involves a two-step model, with signal 1 upregulating NLRP3 expression and signal 2 detecting cellular integrity perturbations.
- Alternative inflammasome activation can be triggered by a single signal, such as LPS or an iNKT cell derived signal.
- Increased sarcoplasmic reticulum (SR) Ca2+ leak and spontaneous SR Ca2+-release events can lead to NLRP3 inflammasome activation.
- Various stimuli, including PAMPs and DAMPs, trigger upstream signaling pathways that converge to activate the NLRP3 inflammasome.
- The EPEC pathogen subverts NLRP3 inflammasome assembly through the effector NleA, which inhibits NLRP3 activation and association with ASC.
- The NLRP3 inflammasome pathway can be involved in epithelial mesenchymal transition (EMT), potentially promoting the EMT process.
Overall, NLRP3 expression and activation are regulated by various transcription factors and signaling pathways, and it plays a role in inflammatory responses, cellular integrity, and EMT processes.
More Common Targets
ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BECN1 | BRAF | BRCA1 | CAMP | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CD8A | CDH1 | CDKN1A | CDKN2A | CREB1 | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | EREG | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA4 | HSPA5 | IDO1 | IFNA1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MDM2 | MET | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SLTM | SMAD4 | SOD1 | SQSTM1 | SRC | STAT1 | STAT3 | STAT5A | TAK1 | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1